CCP
BDSI

Centaur Capital Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Centaur Capital Partners’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,000
Closed -$250K – 36
2015
Q3 		$250K Buy
+45,000
New +$332K 0.38% 33

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Centaur Capital Partners's BDSI Position: Q4 2015 in Review

Centaur Capital Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2015, closing a stake of 45,000 shares — an estimated $250K sold.

Centaur Capital Partners first reported a position in BDSI in Q3 2015 and held it in 1 quarter. The position peaked at $250K in Q3 2015. 126 funds tracked by Wall St. Rank hold BDSI as of Q4 2015.

  • Centaur Capital Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2015 after selling out during the quarter.
  • Centaur Capital Partners sold 45,000 BioDelivery Sciences International, Inc. shares in Q4 2015, an estimated $250K.
  • Centaur Capital Partners first reported a position in BioDelivery Sciences International, Inc. in Q3 2015 and held it in 1 quarter.
  • Centaur Capital Partners's BioDelivery Sciences International, Inc. position peaked at $250K in Q3 2015.
  • 126 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2015.

Based on Centaur Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.